Tuberc Respir Dis.  2006 Mar;60(3):261-269.

Respiratory Symptoms Relievers: Antitussives, Mucolytics, Antihistamines

• Kim SK
• Chang J

Abstract

No abstract available.

MeSH Terms

Antitussive Agents*
Expectorants*
Histamine Antagonists*
Antitussive Agents
Expectorants
Histamine Antagonists

Reference

1. Irwin RS, et al. Managing cough as a defense mechanisms and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 1998. 114:Suppl. 133S–181S.

2. Jeon YJ. Chronic cough. Kor J Med. 2002. 63:118–125.

3. Irwin RS, Madison JM. The diagnosis and treatment of cough. N Engl J Med. 2000. 343:1715–1721.

4. Irwin RS, Madison JM. The persistently troublesome cough. Am J Resp Crit Care Med. 2002. 165:1469–1474.

5. Chang J. Common cold. Kor J Med. 1999. 56:778–780.

6. Chang J. Chronic cough. J Kor Med Assoc. 2002. 45:1331–1342.

7. Chang J. Cough. Kor J Med. 2002. 63:Suppl 2. S500–S512.

8. Yoon JH. Park IY, Yoon JH, Lee JG, Chung IH, editors. Human nasal mucosa histology. Clinical Anatomy of Nose. 2001. 1st ed. Seoul: Academia;32–56.

9. Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol. 1998. 23:403–441.

10. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev. 1998. 50:515–596.

11. van Ganse E, Kaufman L, Derde MO, et al. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials. Eur Respir J. 1997. 10:2216–2224.

12. Spector SL, Nicodemus CF, Corren J, et al. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol. 1995. 96:174–181.

13. Busse WW, Middleton E, Storms W, et al. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med. 1996. 153:122–127.

14. Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2000. 2:CD001287.

15. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ. 2001. 322:1271.

16. Barnes PJ. Murray JF, Nadel JA, Mason RJ, Boushey HA, editors. Chapter 11. Airway pharmacology. Textbook of Respiratory Medicine. 2000. 3rd ed. W.B. Saunders Co;267–296.

17. You JH. Diagnosis and treatment of acute bronchitis The role of antitussives and mucolytics. Med Observer. 2005. 280:27.

18. Scadding G, Mitchell D. Albert RK, Spiro SG, Jett JR, editors. Chapter 28. Rhinitis and Sinusitis. Clinical Respiratory Medicine. 2004. 2nd ed. Mosby Co;347.

19. Hosoe H, Kaise T, Ohmori K, Isohama Y, Kai H, Takahama K, Miyata T. Mucolytic and antitussive effects of erdosteine. J Pharm Pharmacol. 1999. 51:959–966.

20. Oh MY. The Korean Academy of Asthma, Allergy and Clinical Immunology. Chapter 2. Types and mechanisms of hypersensitivity. Asthma and Allergic diseases. 2002. Koonja Publishing;13–16.

21. Yoon JH. The Korean Academy of Asthma, Allergy and Clinical Immunology. Chapter 11. Mucus. Asthma and Allergic diseases. 2002. Koonja Publishing;73–77.

22. Decramer M, Rutten-van Molken M, Dekhuijen PNR, Troosters T, van Herwaarden C, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCHUS): a randomized placebo-controlled trial. Lancet. 2005. 365:1552–1560.